COMMUNIQUÉS West-GlobeNewswire

-
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
18/09/2018 -
Rexahn Pharmaceuticals to Present at the 5th NCI Pancreatic Cancer Symposium
18/09/2018 -
Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities
18/09/2018 -
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
18/09/2018 -
Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
18/09/2018 -
Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar
18/09/2018 -
resTORbio Appoints Meredith Manning as Chief Commercial Officer
18/09/2018 -
CrownBio octroie des licences de modèles de résistance et de métastase pour le cancer du sein translationnel
18/09/2018 -
Progressive Care Inc. Announces Record Number of Prescriptions Filled and Strong Revenues During August 2018
18/09/2018 -
NSVRC releases updated Sexual Assault Response Team (SART) Toolkit
18/09/2018 -
Melinta Therapeutics Names Peter Milligan as Chief Financial Officer
18/09/2018 -
Tyme Appoints Accomplished Healthcare Executive Douglas A. Michels to Board of Directors
18/09/2018 -
Chiesi Salutes Nurses Surrounding Neonatal Nurses Day 2018
18/09/2018 -
Vystar Introduces Vytex Cloud: World’s First Ultra-Soft 55 Density Natural Latex Mattress Topper
18/09/2018 -
Eyenovia to Present at the Ladenburg Thalmann 2018 Healthcare Conference
18/09/2018 -
Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer
18/09/2018 -
Strongbridge Biopharma plc to Participate in Two Upcoming Healthcare Investor Conferences
18/09/2018 -
IMV Inc. Announces Early Positive Results from Phase 2 Clinical Trial of Lead Candidate DPX-Survivac in Combination with Merck’s Keytruda® in Patients with DLBCL
18/09/2018 -
The Joint Corp. to Participate in Two Fall Investor Conferences
18/09/2018
Pages